HOME › Research Insight › Biomedical Research and Preclinical Trials in Asia-Pacific (China, Japan, Singapore, Malaysia, Taiwan, and Korea) are the New Revenue Pockets for the Mice Model and Services Market
Biomedical Research and Preclinical Trials in Asia-Pacific (China, Japan, Singapore, Malaysia, Taiwan, and Korea) are the New Revenue Pockets for the Mice Model and Services Market
Mice models are the most commonly used animal models for biomedical research, preclinical trials, and development of unique animal models for specific purposes. Over the next five years, growth in the mice model market is likely to be centered at China, Japan, Singapore, Malaysia, Taiwan, and Korea. Furthermore, the mice model market in Australia and New Zealand is expected to grow in the forecast period, due to ongoing biomedical research activities and government initiatives to support research projects, which is resulting in the increase in demand for mice models.
The mandatory animal testing for cosmetics and pharmaceutical compounds as well as increasing R&D activities in China are some of the factors that are creating a significant demand for mice models. China’s 11th Five-Year Plan provided an impetus for advancements in technology and commercialization of materials for biomedical applications, while the 12th Five-Year Plan would provide financial support and government industrial policy incentives to the biotechnology industry in China. These factors are expected to propel the market for mice models, which are extensively used in research activities.
Singapore has been investing heavily in translation research. Between 2006 and 2010, the Singapore government invested $1.5 billion in translational research on a project named Biomedical Sciences Initiative. This investment was utilized for developing infrastructure for translation research; it included the development of imaging, animal testing, and early-stage clinical trial facilities. Such investments are likely to result in the growth in usage of mice models. Japan has witnessed a large number of research projects related to regenerative medicine. For instance, in July 2013, a group of Japanese scientists from Yokohama City University Graduate School of Medicine reported the growth of a liver bud in a laboratory mouse. This research involved the use of stem cells to grow a human liver in laboratory mice. Such research activities are expected to increase the demand for mice models for experimental purposes.
Currently, various universities and organizations in Malaysia are involved in neuroscience research, which extensively uses mice models to study neurological disorders such as autism, schizophrenia, Down’s syndrome, and Alzheimer’s disease. The mice model market in Taiwan is expected to witness significant growth, owing to the continuous government support for R&D activities in Taiwan (including preclinical research), growth in the number of biomedical research projects at various academic and research institutes, and initiation of research programs that are resulting in an increase in demand for mice models. In addition, Taiwan is witnessing a growth in its biotechnology industry, due to funding programs such as the Taiwan Medtech Funds which support startup biotechnology ventures. Likewise, Korea is highly focused on developing its biotechnology and pharmaceutical sectors and the Korean government is undertaking various initiatives like Pharma 2020 Vision and Bio-Vision 2016, for this purpose. The growth in pharmaceutical and biotechnology sectors is increasing the scope for R&D activities and preclinical studies, thereby creating a demand for mice models.
Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252